Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles Post author: Post published:April 5, 2024 Post category:uncategorized Recombinant adeno-associated virus (rAAV)-based genetic applications to treat human diseases. You Might Also Like Dopamine treatment can reduce Alzheimer’s plaques and improve memory August 6, 2024 Scientists uncover why SETX-deficient cancer cells rely on error-prone DNA repair December 4, 2025 Cerebellar structural changes influence social behavior in autism June 12, 2026